Naproxen Sodium
- Product NDC
- 62037-825
- 11-digit product format
- 620370825
- Labeler code
- 62037
- Product ID
- 62037-825_151ee0f3-bd75-4e9f-83b5-12d33ca3b27c
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- naproxen sodium
- Dosage form
- TABLET, FILM COATED, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Actavis Pharma, Inc.
- Application
- ANDA075416
- Marketing category
- ANDA
- Marketing start
- 2014-09-30
- Marketing end
- 0000-00-00
- Substance
- NAPROXEN SODIUM
- Active strength
- 375 mg/1
- Pharmacologic classes
- Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 62037-825-01 | 62037082501 | 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (62037-825-01) | 2014-09-30 | 0000-00-00 | No | No | Current |